Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 3,115 | 4,802 | 4,375 | 4,223 | 4,597 |
| Operating Income | -3,115 | -4,802 | -4,375 | -4,223 | -4,597 |
| Interest Expense | 69 | 81 | 84 | 88 | 133 |
| Other Income | -184 | 372 | 146 | -2,059 | -1,040 |
| Pre-tax Income | -3,368 | -4,511 | -4,313 | -6,370 | -5,771 |
| Net Income Continuous | -3,368 | -4,512 | -4,313 | -6,370 | -5,770 |
| Net Income | $-3,368 | $-4,512 | $-4,313 | $-6,370 | $-5,770 |
| EPS Basic Total Ops | -0.68 | -0.68 | -1.19 | -2.21 | -2.38 |
| EPS Basic Continuous Ops | -0.70 | -0.72 | -1.13 | -2.18 | -2.37 |
| EPS Diluted Total Ops | -0.68 | -0.68 | -1.19 | -2.21 | -2.38 |
| EPS Diluted Continuous Ops | -0.70 | -0.72 | -1.13 | -2.18 | -2.37 |
| EBITDA(a) | $-3,049 | $-4,797 | $-4,370 | $-4,221 | $-4,606 |